BLOG

Get to know Francis Douville, Senior Vice President of Technical Operations at Altasciences' preclinical facility in Seattle, Washington.

Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making early on for important milestones, and ultimately getting your molecule from discovery to market efficiently.

Artificial intelligence, or AI, has been on the radar screen as a possible tool to improve drug development, and clinical trial design and conduct for some time. This month's blog covers some of the advancements.

Get to know David Grégoire, Vice President of Compliance and Regulatory Affairs at Altasciences.

Adverse drug reactions caused by individual drugs and drug combinations contribute to one of the top 10 causes of death in the United States. This blog offers insight on minimizing the risks with DDI studies.

Different types of vaccines, and why some require more than one dose.